Elsewhere on HealthThreads: Lymphoma | Stomach cancer | Overactive bladder | Thyroid cancer |
UroToday (www.urotoday.com) has great Bladder cancer news, photos, videos and more
Carcinoma of the urinary bladder involves alterations in multiple cellular pathways that dictate the pathology of the disease and clinical outcome of the ...
Bacillus Calmette-Guérin (BCG) remains the most effective intravesical treatment for non-muscle-invasive bladder cancer (NMIBC), but the clinical ...
International Bladder Cancer Nomogram Consortium and the clinical outcomes in a multicenter Italian cohort of patients treated with radical cystectomy ...
It would be helpful to explore the precise mechanism of action of menthol in bladder cancer with a view to its possible use as intravesical chemotherapy.
From 2005 to 2009, 173 patients with primary non-muscle invasive bladder cancer underwent endoscopic surgery. Among them, 51 patients underwent CM-TURBT, ...
Two studies suggest benefit from neo-adjuvant chemotherapy. The SWOG 87-10 compared cystectomy alone or with neoadjuvant MVAC and a survival benefit was ... SUO 2009 - Recent advances in bladder cancer: Bladder cancer targeted ...UroToday all 2 news articles »
His study analyzed 2222 bladder cancer patients with negative cytology. NMP22 improved AUC for recurrence by 12% and progression by 24%. ...
Methylation changes in urine from bladder cancer patients were first reported in 2002. DNA methylation can happen early on in the disease process or later ...
BETHESDA, MD, USA (UroToday.com) - Dr. Michael Droller led the discussion by asking how urinary markers will compare with new imaging technologies to detect ... SUO 2009 - Overview: Quality measures of endoscopic staging and NBI - Session ...UroToday
The necessary equipment is available in many centers that perform PDD for urothelial bladder cancer. PDD, therefore, can be considered to be cost-effective ...
To estimate the relative risk of developing a second primary neoplasm, in particular lung cancer, after having non-muscle-invasive bladder cancer (NMIBC). ...
The rate of continent urinary diversion after radical cystectomy for bladder cancer varies by patient and provider characteristics. ...
The objective of this study was to evaluate the expression patterns of cell cycle-associated proteins in newly diagnosed non-muscle-invasive bladder cancer ...
To correlate urinary bikunin levels with clinical significance we examined urine samples from patients with bladder cancer and normal controls for bikunin ...
To investigate the association between expression levels of topoisomerase-II alpha (TOP-2alpha) and prognosis in primary non-muscle-invasive bladder cancer ...
Most novel agents used to treat bacillus Calmette-Guerin refractory high-grade non-muscle-invasive (NMI) bladder cancer are evaluated only after short ...
The aim of this study was to evaluate, in human urothelial bladder cancer (UBC), the clinical and prognostic significance of angiogenesis, lymphangiogenesis ...
The role of pelvic lymphadenectomy in patients with lymph node-negative bladder cancer at radical cystectomy (RC) has not yet been examined in detail. ...
To assess the current status of robot-assisted radical cystectomy with pelvic lymphadenectomy and urinary diversion for the treatment of bladder cancer. ...
CA Cystoscopy is the method of choice for evaluation of the primary tumor in patients with bladder carcinoma. Imaging acts as an adjunct to accurately stage disease in these patients. Nearly 2-4% of patients with bladder cancer develop upper tract TCC. ...
CA To evaluate molecular and immunohistochemical markers to develop a molecular grading of urothelial bladder cancer and to test these markers in voided urine samples. Experimental Design: 255 consecutive biopsies from primary bladder cancer patients were ...
CA Four consecutive patients were selected with muscle invasive bladder cancer receiving radical dose radiation therapy. Four radiation oncologists specializing in genitourinary malignancies contoured the clinical target volume (CTV) and rectum on both a ...
CA Examine factors influencing the use of combination chemotherapy plus cystectomy and use of specific chemotherapy drugs over time for bladder cancer. Data from the SEER-Medicare database were analyzed for patients diagnosed with urothelial carcinoma of ...
CA Division of Urology, Columbia University, Mount Sinai Medical Center, Miami Beach and Department of Epidemiology and Public Health, University of Miami Miller School of Medicine, Miami, Florida. Modifiable risk factors for bladder cancer have been ...
CA NMP22(R) BladderChek(R) testing was performed on voided urine samples. Those with positive test results underwent office cystoscopy and cytology testing. Participants were contacted for followup at 12 months after study enrollment to evaluate for ...
CA We relied on life tables to quantify 30, 60 and 90-day mortality rates according to age, gender, stage (localized vs regional), grade, type of surgery (partial vs radical cystectomy), year of cystectomy and histological bladder cancer subtype. ...
CA We determined the associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy. The Alberta Urology Institute Radical Cystectomy database is an ongoing multi-institutional computerized database ...
CA Using data of the French national mortality statistics (INSERM) during a 21-year period, 1979-1999, we compared the observed number of deaths from renal and bladder cancer in DS subjects with the expected number of deaths from these cancers. ...
CA US findings were compared with cystoscopy findings and the pathological stage after a TURB or a radical cystectomy in a double-blinded manner. The sensitivity of preoperative tumor staging was 67.9% for 2D US and sensitivity was 78.6% for 3D US. ...
CA To determine the potential for hexylaminolevulinate (HAL) photodynamic diagnosis (PDD) to improve the management of multifocal recurrent nonmuscle-invasive bladder cancer (NMIBC). Patients with a history of NMIBC and with at least two suspected ...
CA We compared its gene expression in urothelium biopsy and tumor specimens from patients who had undergone BCG immunotherapy. Patients with nonmuscle-invasive bladder cancer were divided into 3 groups, according to the cancer recurrence status: group 1, ...
CA To evaluate long-term survival after radical cystectomy (RC) for bladder cancer (BC) and to define risk factors for BC-specific death. Patients having RC for BC with curative intent in Turku University Hospital 1986-2005 were assessed. ...
CA One of the first signs is blood in the urine (hematuria). Other signs can include painful urination, increased frequency of urination, a feeling of needing to urinate but not being able to do so, and chronic bladder inflammation from recurrent urinary ...
Treatment delays have been associated with adverse outcomes in patients with bladder cancer treated with radical cystectomy (RC). We sought to evaluate the impact of treatment delay on disease recurrence and survival in patients with bladder cancer ...
CA Transitional cell carcinoma (TCC) is the most common form of bladder cancer. In bladder cancer, which in terms of its origins and genetics, is a representative of invasive tumors, the differing clinical course and the limited value of established ...
CA Patients with non-muscle-invasive bladder cancer with an intermediate or high risk need adjuvant intravesical therapy after surgery. Based largely on meta-analyses of previously published results, guidelines recommend using either bacillus ...
MedIndia CA The object of this study was to examine trends in bladder cancer survival among four ethnic groups in the US over a 30 year period. The SEER database was used to identify patients diagnosed with transitional cell carcinoma of the bladder between 1975 ...
CA Guidelines indicate that a patient with a pT1G3 tumor should initially receive BCG intravescial therapy, although cystectomy can be considered. In case of a recurrence, cystectomy is the treatment of choice. Although several new drugs and strategies ...
CA To quantify the relation between secondhand smoking (SHS) and levels of 4-aminobiphenyl (4-ABP; in urine or blood) and SHS and bladder cancer risk in nonsmokers. PubMed and Embase were searched (search terms to represent SHS, bladder cancer, ...